HighTower Advisors’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.19M | Sell |
|
|||||
|
2025
Q1 | $3.24M | Buy |
|
|||||
|
2024
Q4 | $2.73M | Buy |
|
|||||
|
2024
Q3 | $2.15M | Buy |
|
|||||
|
2024
Q2 | $219K | Sell |
|
|||||
|
2024
Q1 | $626K | Sell |
|
|||||
|
2023
Q4 | $801K | Buy |
|
|||||
|
2023
Q3 | $681K | Buy |
|
|||||
|
2023
Q2 | $429K | Buy |
|
|||||
|
2023
Q1 | $478K | Sell |
|
|||||
|
2022
Q4 | $527K | Buy |
|
|||||
|
2022
Q3 | $406K | Sell |
|
|||||
|
2022
Q2 | $817K | Sell |
|
|||||
|
2022
Q1 | $808K | Sell |
|
|||||
|
2021
Q4 | $1.84M | Buy |
|
|||||
|
2021
Q3 | $1.11M | Buy |
|
|||||
|
2021
Q2 | $378K | Buy |
|
|||||
|
2021
Q1 | $319K | Buy |
|
|||||
|
2020
Q4 | $353K | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $281K | Sell |
|
|||||
|
2020
Q1 | $201K | Sell |
|
|||||
|
2019
Q4 | $208K | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $438K | Sell |
|
|||||
|
2019
Q1 | $535K | Sell |
|
|||||
|
2018
Q4 | $530K | Buy |
|
|||||
|
2018
Q3 | $493K | Buy |
|
|||||
|
2018
Q2 | $479K | Buy |
|
|||||
|
2018
Q1 | $264K | Sell |
|
|||||
|
2017
Q4 | $339K | Buy |
|
|||||
|
2017
Q3 | $244K | Sell |
|
|||||
|
2017
Q2 | $282K | Buy |
|
|||||
|
2016
Q2 | – | Sell |
|
|||||
|
2016
Q1 | $285K | Sell |
|
|||||
|
2015
Q4 | $553K | Buy |
|
|||||
|
2015
Q3 | $280K | Buy |
|
|||||
|
2015
Q1 | – | Sell |
|
|||||
|
2014
Q4 | $230K | Buy |
|
|||||
|
2014
Q1 | – | Sell |
|
|||||
|
2013
Q4 | $228K | Buy |
|